At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BK4139 Biotechnology
Market Closed 07-10 16:00:00 EDT
79.29
-1.72
-2.13%
High81.19Low78.73Vol592.01M
Open81.01D1 Closing81.01Amplitude3.03%
Mkt Cap0.00Tradable Cap0.00Total Shares0.00
T/O16.63BT/O Rate--Tradable Shares0.00
P/B7.767624ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Notification Regarding Unquoted Securities - Avh-rcel.o
Reuters  ·  53 minutes ago
Notification Regarding Unquoted Securities - Avh-rcel.o
Cellectar Biosciences initiated with a Buy at Brookline
TIPRANKS  ·  05:55
Cellectar Biosciences initiated with a Buy at Brookline
EQ Resources Expands Queensland Tungsten Footprint
MT Newswires Live  ·  05:40
EQ Resources Expands Queensland Tungsten Footprint
Incyte (INCY) Could Be 8% Overvalued After Its 22% Three Month Run
Simply Wall St.  ·  01:19
Incyte (INCY) Could Be 8% Overvalued After Its 22% Three Month Run
Subcutaneous Leqembi Autoinjector Matches IV Exposure, Promises More Flexible Alzheimer’s Care
TIPRANKS  ·  00:02
Subcutaneous Leqembi Autoinjector Matches IV Exposure, Promises More Flexible Alzheimer’s Care
Biogen, Eisai announce new data on efficacy, safety of LEQEMBI SC-AI
TIPRANKS  ·  07-12 23:50
Biogen, Eisai announce new data on efficacy, safety of LEQEMBI SC-AI
Evaxion Presents New Preclinical Data for CMV Vaccine Program Evx-v1
Reuters  ·  07-12 21:47
Evaxion Presents New Preclinical Data for CMV Vaccine Program Evx-v1
Hemab Therapeutics presents new clinical data from HMB-002 in VWD
TIPRANKS  ·  07-12 21:45
Hemab Therapeutics presents new clinical data from HMB-002 in VWD
Evaxion presents new preclinical data for cytomegalovirus vaccine program EVX-V1
GlobeNewswire  ·  07-12 21:30
Evaxion presents new preclinical data for cytomegalovirus vaccine program EVX-V1
Hemab Therapeutics Presents New Clinical Data from HMB-002 in Von Willebrand Disease and Introduces HMB-003 for Heavy Menstrual Bleeding at the ISTH 2026 Congress
GlobeNewswire  ·  07-12 18:28
Hemab Therapeutics Presents New Clinical Data from HMB-002 in Von Willebrand Disease and Introduces HMB-003 for Heavy Menstrual Bleeding at the ISTH 2026 Congress
Asia's Largest ACGN Expo Draws 400,000 Attendees Over Three Days
Deep News  ·  07-12 14:30
Asia's Largest ACGN Expo Draws 400,000 Attendees Over Three Days
Scholar Rock Holding (SRRK) Rallies As Pipeline Story Meets A Fair Value Question
Simply Wall St.  ·  07-12 14:25
Scholar Rock Holding (SRRK) Rallies As Pipeline Story Meets A Fair Value Question
How Myqorzo’s US and German Launches Will Impact Cytokinetics (CYTK) Investors
Simply Wall St.  ·  07-12 12:29
How Myqorzo’s US and German Launches Will Impact Cytokinetics (CYTK) Investors
3 Fast Growing ASX Stocks With High Insider Ownership to Watch
Simply Wall St.  ·  07-12 12:26
3 Fast Growing ASX Stocks With High Insider Ownership to Watch
Ascendis Pharma (ASND) Says 104 Week TransCon CNP Data Still Looks Strong
Simply Wall St.  ·  07-12 11:35
Ascendis Pharma (ASND) Says 104 Week TransCon CNP Data Still Looks Strong
Vivani Stock Puts These Obesity And Diabetes Treatment Stocks On The Radar
Simply Wall St.  ·  07-12 03:24
Vivani Stock Puts These Obesity And Diabetes Treatment Stocks On The Radar
Analysts Are Bullish on These Healthcare Stocks: Immunome (IMNM), COMPASS Pathways (CMPS)
TIPRANKS  ·  07-11 22:40
Analysts Are Bullish on These Healthcare Stocks: Immunome (IMNM), COMPASS Pathways (CMPS)
Tenax Therapeutics (TENX) Gets a Buy from LifeSci Capital
TIPRANKS  ·  07-11 22:35
Tenax Therapeutics (TENX) Gets a Buy from LifeSci Capital
LifeSci Capital Remains a Buy on Prime Medicine, Inc. (PRME)
TIPRANKS  ·  07-11 22:35
LifeSci Capital Remains a Buy on Prime Medicine, Inc. (PRME)
Neurogene (NGNE) Receives a Buy from LifeSci Capital
TIPRANKS  ·  07-11 22:35
Neurogene (NGNE) Receives a Buy from LifeSci Capital

Introduction

Company Name.
BK4139
Affiliated Markets:
Listing Date:
--
Main Business:
Issue price:
--